NBIX stock news
This page provides real-time market news, earnings updates, and company announcements related to Neurocrine Biosciences, Inc. (NBIX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-16 16:34 EST
New Strong Sell Stocks for February 18th
Finviz2026-02-18 10:21:36
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
Finviz2026-02-19 02:36:45
Truist Lowers Neurocrine Biosciences, Inc.'s (NBIX) PT Following 2026 Outlook Update
Finviz2026-02-23 21:33:11
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:06:42
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-09 20:06:47
Financial Data Highlights: Ovid Therapeutics Inc. (NASDAQ: OVID) reported in its latest financial statement that as of December 31, 2025, the company held a total of $90.4 million in cash, cash equivalents, and marketable securities.
老虎证券2026-03-18 10:23:26
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Finviz2026-03-26 12:31:08
Reports indicate that Neurocrine Biosciences is about to acquire Soleno Therapeutics at a price of approximately $2.5 billions, prompting Soleno Therapeutics' shares to surge 30% in pre-market trading.
老虎证券2026-04-06 09:03:42
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Finviz2026-04-06 11:03:56
According to the latest disclosed agreement terms, if the acquisition is terminated under specific circumstances, Soleno Therapeutics (SLNO) will be required to pay Neurocrine Biosciences (NBIX) a termination fee of up to 953 millions dollars.
老虎证券2026-04-06 12:08:02
US Stocks Movement | Soleno surges over 33% after being acquired by Neurocrine for $2.9 billions
格隆汇2026-04-06 13:39:11
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results
Finviz2026-04-14 20:03:08
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-09 20:06:47
Financial Data Highlights: Ovid Therapeutics Inc. (NASDAQ: OVID) reported in its latest financial statement that as of December 31, 2025, the company held a total of $90.4 million in cash, cash equivalents, and marketable securities.
老虎证券2026-03-18 10:23:26
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Finviz2026-03-26 12:31:08
Reports indicate that Neurocrine Biosciences is about to acquire Soleno Therapeutics at a price of approximately $2.5 billions, prompting Soleno Therapeutics' shares to surge 30% in pre-market trading.
老虎证券2026-04-06 09:03:42
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Finviz2026-04-06 11:03:56
According to the latest disclosed agreement terms, if the acquisition is terminated under specific circumstances, Soleno Therapeutics (SLNO) will be required to pay Neurocrine Biosciences (NBIX) a termination fee of up to 953 millions dollars.
老虎证券2026-04-06 12:08:02
US Stocks Movement | Soleno surges over 33% after being acquired by Neurocrine for $2.9 billions
格隆汇2026-04-06 13:39:11
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2026 Financial Results
Finviz2026-04-14 20:03:08
NBIX stock chart
NBIX stock detailsNBIX stock price change
On the last trading day, NBIX stock closed at 130.81 USD, with a price change of 3.55% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more